FDA to monitor oxygen sales at manufacturing units and hospitals

Concerns around shortage of medical oxygen in the wake of a staggering rise in the district’s Covid cases have propelled the food and drug administration (FDA) authorities to undertake an orchestrated drive at manufacturing units, re-fillers and the private hospitals earmarked for Covid treatment in order to monitor sales, dispatches, deliveries, supplies and stocks. The authorities are set to check the distribution channels too.
Read more...

;